15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of N-(2-oxoethyl) sulfanilamide-derived inhibitors of KAT6A (MOZ) against leukemia by an isostere strategy.

Children's Hospital Affiliated to Zhengzhou University
Acetyl-Click Screening Platform Identifies Small-Molecule Inhibitors of Histone Acetyltransferase 1 (HAT1).

Wayne State University
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8.

Sapienza University of Rome
Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor.

Daiichi Sankyo Co.
Discovery of EP300/CBP histone acetyltransferase inhibitors through scaffold hopping of 1,4-oxazepane ring.

Daiichi Sankyo
4-Pyridone-3-carboxylic acid as a benzoic acid bioisostere: Design, synthesis, and evaluation of EP300/CBP histone acetyltransferase inhibitors.

Daiichi Sankyo
Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.

Sichuan University
Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A.

Cancer Therapeutics Crc
ANTIBIOTIC PYRAZINOTHIAZINE DERIVATIVES AND PROCESS OF PREPARATION THEREOF

Bugworks Research India
FUNCTIONALIZED AMINOTHIAZOLES

Leadxpro
Substituted heterocycles as aldehyde dehydrogenase inhibitors

Kayothera
Mu opioid receptor modulators

University of California
2,3-dihydrofuro[2,3-b]pyridine compounds

Eli Lilly
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

The Institute of Cancer Research: Royal Cancer Hospital